Glaxosmithkline Biologicals S.A.
GlaxoSmithKline Biologicals S.A., commonly referred to as GSK Biologicals, is a leading global player in the biopharmaceutical industry, headquartered in Belgium. Founded in 1995, the company has established itself as a pioneer in vaccine development, focusing on innovative solutions to combat infectious diseases. With a strong operational presence across Europe, North America, and emerging markets, GSK Biologicals is dedicated to enhancing public health through its extensive portfolio of vaccines.
The company’s core offerings include vaccines for diseases such as influenza, hepatitis, and meningitis, distinguished by their advanced research and development processes. GSK Biologicals has achieved notable milestones, including the introduction of several groundbreaking vaccines that have significantly impacted global health. As a subsidiary of GlaxoSmithKline plc, it continues to maintain a robust market position, recognised for its commitment to quality and innovation in the biopharmaceutical sector.
+62 vs industry average
Glaxosmithkline Biologicals S.A.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Glaxosmithkline Biologicals S.A.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Glaxosmithkline Biologicals S.A. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Glaxosmithkline Biologicals S.A.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Glaxosmithkline Biologicals S.A. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from GSK plc
Carbon Disclosure Project
Inherited from GSK plcThe Climate Pledge
Inherited from GSK plcUN Global Compact Climate Champions initiative
Inherited from GSK plcRE 100
Inherited from GSK plcClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project